Blood Cancer Discovery Issues Research Articles in March 2022 Edition
March 25, 2022
March 25, 2022
PHILADELPHIA, Pennsylvania, March 25 -- Blood Cancer Discovery, a peer reviewed journal from the American Association for Cancer Research that says it covers advances in basic, translational and clinical research of leukemia, lymphoma, myeloma and associated diseases, published research articles on the following topics in its March 2022 edition:
Research Articles:
* BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 fro . . .
Research Articles:
* BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 fro . . .